SVP and Chief Technical Officer Michael J. Labarre sold $340K of Halozyme Therapeutics, Inc.

Sold$339,564

$28.30Price

12,000Shares

−7%Stake

What HALO did after the filing

Prices for HALO after this filing aren't in yet.

Traded Thu, Aug 20. Filed Thu, Aug 20, 12:21 PM ET, during the session. Not investment advice.